These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 26114756)
1. Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis. Liao Q; Han P; Huang Y; Wu Z; Chen Q; Li S; Ye J; Wu X PLoS One; 2015; 10(6):e0130677. PubMed ID: 26114756 [TBL] [Abstract][Full Text] [Related]
2. Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma. Huang JT; Liu SM; Ma H; Yang Y; Zhang X; Sun H; Zhang X; Xu J; Wang J J Cell Physiol; 2016 Feb; 231(2):328-35. PubMed ID: 26291451 [TBL] [Abstract][Full Text] [Related]
3. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis. Li G; Shen Q; Li C; Li D; Chen J; He M Clin Transl Oncol; 2015 Sep; 17(9):684-93. PubMed ID: 25956842 [TBL] [Abstract][Full Text] [Related]
4. Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis. Yan SR; Liu ZJ; Yu S; Bao YX Genet Mol Res; 2015 Sep; 14(3):11573-86. PubMed ID: 26436398 [TBL] [Abstract][Full Text] [Related]
5. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of circulating microRNAs for hepatocellular carcinoma. Yang Y; Zhu R Mol Biol Rep; 2014 Oct; 41(10):6919-29. PubMed ID: 25030834 [TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China. Jiang L; Cheng Q; Zhang BH; Zhang MZ Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Zheng C; Hao H; Chen L; Shao J Clin Transl Oncol; 2017 Aug; 19(8):961-968. PubMed ID: 28188488 [TBL] [Abstract][Full Text] [Related]
9. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening. Jiang L; Li X; Cheng Q; Zhang BH Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380 [TBL] [Abstract][Full Text] [Related]
10. Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis. Zhao XF; Li N; Lin DD; Sun LB Biomed Res Int; 2020; 2020():5353695. PubMed ID: 32309434 [TBL] [Abstract][Full Text] [Related]
11. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model. Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032 [TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology. Sartorius K; Sartorius B; Kramvis A; Singh E; Turchinovich A; Burwinkel B; Madiba T; Winkler CA BMC Cancer; 2017 Dec; 17(1):894. PubMed ID: 29282036 [TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function. Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777 [TBL] [Abstract][Full Text] [Related]
14. Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma. Dhayat SA; Hüsing A; Senninger N; Schmidt HH; Haier J; Wolters H; Kabar I PLoS One; 2015; 10(10):e0140066. PubMed ID: 26447841 [TBL] [Abstract][Full Text] [Related]
15. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker. Anwar SL; Albat C; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U Int J Cancer; 2013 Aug; 133(3):660-70. PubMed ID: 23364900 [TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma. Fang Y; Yan D; Wang L; Zhang J; He Q J Clin Lab Anal; 2022 Jul; 36(7):e24541. PubMed ID: 35666610 [TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma. Ali HEA; Abdel Hameed R; Effat H; Ahmed EK; Atef AA; Sharawi SK; Ali M; Abd Elmageed ZY; Abdel Wahab AH Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):e51-e62. PubMed ID: 28750770 [TBL] [Abstract][Full Text] [Related]
18. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839 [TBL] [Abstract][Full Text] [Related]
19. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients. Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as a novel class of diagnostic biomarkers in detection of hepatocellular carcinoma: a meta-analysis. Yin H; Peng X; Ren P; Cheng B; Li S; Qin C Tumour Biol; 2014 Dec; 35(12):12317-26. PubMed ID: 25204672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]